Scientists have identified proteins in the blood and cerebrospinal fluid that reflect nerve cell damage. The results of the study suggest that the concentration of these 'neurofilament light chain proteins' could provide information about the progression of neurodegenerative diseases and the effects of treatment. Such a biomarker would be valuable for developing therapies.